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Abstract
 
The airway mucosal response to allergen in asthma involves influx of activated T helper type 2
cells and eosinophils, transient airflow obstruction, and airways hyperresponsiveness (AHR).
The mechanism(s) underlying transient T cell activation during this inflammatory response is
unclear. We present evidence that this response is regulated via bidirectional interactions be-
tween airway mucosal dendritic cells (AMDC) and T memory cells. After aerosol challenge,
resident AMDC acquire antigen and rapidly mature into potent antigen-presenting cells (APCs)
after cognate interactions with T memory cells. This process is restricted to dendritic cells (DCs)
in the mucosae of the conducting airways, and is not seen in peripheral lung. Within 24 h,
antigen-bearing mature DCs disappear from the airway wall, leaving in their wake activated
 
interleukin 2R
 
  
 
T cells and AHR. Antigen-bearing activated DCs appear in regional lymph
nodes at 24 h, suggesting onward migration from the airway. Transient up-regulation of CD86
on AMDC accompanies this process, which can be reproduced by coculture of resting AMDC
with T memory cells plus antigen. The APC activity of AMDC can be partially inhibited by
anti-CD86, suggesting that CD86 may play an active role in this process and/or is a surrogate
for other relevant costimulators. These findings provide a plausible model for local T cell activa-
tion at the lesional site in asthma, and for the transient nature of this inflammatory response.
Key words: dendritic cells • asthma • respiratory mucosa • T cells • activation
 
Introduction
 
Airflow obstruction during asthma exacerbations is held to
be the result of chronic inflammatory changes in the mu-
cosal tissues of the conducting airways, leading to structural
alterations, in particular airway wall thickening (1, 2). Al-
though the remodelling in the small airways makes the
largest contribution to airflow obstruction during asthma
attacks, it is clear that the remodelling and associated in-
flammation occurs throughout the small and large conduct-
ing airways (2, 3), whereas parenchymal lung tissues display
minimal involvement.
A variety of evidence implicates the products of activated
T cells as trigger factors in this process (4, 5). However it is
not known whether activation occurs locally at site(s) of
deposition of inhaled allergen in the respiratory tree, or at
distal locations such as regional lymph nodes (RLN),
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challenge. The resolution of this question is central to the
development of more effective antiinflammatory drugs for
asthma control.
A key issue in this regard concerns the functional pheno-
type of local APC populations within the airway mucosae.
This tissue compartment represents an anatomically and
functionally distinct entity within the respiratory tree, be-
ing part of the common mucosal immune system (6) and
hence part of the circuit through which mucosal-homing T
cells selectively recirculate. The resident APCs in this com-
partment comprise dense populations of DCs distributed in
networks analogous to the epidermis (7, 8). In resting air-
way mucosa they exhibit a uniquely rapid turnover (9),
providing efficient local immune surveillance of antigens
impacting on the conducting airway surface. Paradoxically,
they exhibit the “immature” DC phenotype, and can
readily acquire inhaled allergen, but lack capacity for effec-
tive presentation to T cells (10, 11). There is thus no plau-
sible mechanism for delivery of the allergen-specific signals
that initiate local T cell activation in the airway mucosa in
atopic asthma, and the resolution of this issue represented
the aim of this study.
Previous studies on the role of respiratory tract DCs in
control of T cell activation in experimental asthma have fo-
cused principally upon populations that are readily accessi-
ble by bronchoalveolar lavage (BAL), or the large DC pop-
ulation harvested from enzymatically disrupted whole lungs
(12, 13), the latter being dominated by nonmucosal DCs
from parenchymal lung. This study is the first to focus on
the role of DCs from isolated conducting airways in exper-
imental asthma, and we demonstrate a sequence of pheno-
typic and functional changes in these airway DCs after
aeroallergen challenge that are unique to this tissue com-
partment and not reflected in DC populations from the pe-
ripheral lung in the same animals.
 
Materials and Methods
 
Animals and Allergen Exposures.
 
Inbred PVG rats were bred
and maintained free of pathogens. Randomly selected animals of
both sexes aged 8–13 wk were used. Presensitization of animals to
OVA was achieved by intraperitoneal immunization with OVA
in aluminum hydroxide (OVA/ALOH), which elicits Th2-polar-
ized responses characterized by IgE antibody production, or
OVA in complete Freund’s adjuvant, which elicits Th1 immunity
involving only IgG antibody production, using standard methods
(10, 14, 15). The animals were used for aerosol challenge experi-
ments 14–21 d later. Aerosol challenge was performed over a 1-h
period as per earlier publications (15, 16).
 
Media and Reagents.
 
The tissue culture medium and isolation
reagents used are as previously described (11). Details of mAbs and
immunostaining reagents are as previously reported (8, 11, 16).
OVA, mepyramine, and methysergide were from Sigma-Aldrich.
FITC-conjugated dextran (Mr 
 
  
 
40 kD) for endocytosis and
tracking experiments was purchased from Molecular Probes.
 
Cell Preparation and Culture.
 
Collagenase A digests of lung
and trachea were prepared by standard methods and depleted of
macrophages and B cells as previously described (11, 16). Dispase
was added at a final concentration of 1.25 mg/ml. Peripheral seg-
 
ments of lung were dissected free of hilar tissue before digestion
to minimize contamination with conducting airway mucosal
cells. DCs were purified by dual parameter cell sorting (11). This
procedure yields cell populations in which macrophages and B
cells are essentially undetectable and CD3
 
  
 
T cells and cytokera-
tin-positive epithelial cells are 
 
 
 
3%, the dominant population be-
ing 
 
 
 
95% MHC class II moderate-high putative DCs (see Fig.
S1, available at http://www.jem.org/cgi/content/full/jem.20021328/
DC1). In some experiments, CD4
 
  
 
T cells were also purified
from lymphoid organs using comparable methodology. DC/T
cell coculture experiments used previously described methodol-
ogy (10, 11). Presentation of OVA by DCs from trachea or
lymph nodes of OVA aerosol–exposed animals used standard tis-
sue culture techniques reported previously (11, 16). The genera-
tion of the OVA-responsive CD4
 
  
 
T cell lines was performed ac-
cording to a previously described protocol (17).
 
Quantitative and Qualitative Analyses of Cell Populations.
 
The
methodology for immunohistochemical analysis and quantitation
of cell types in tangential frozen sections of airway mucosal tissues
is as previously described (7, 8, 11) and DC designation is based
on MHC class II expression plus dendritiform morphology, in
the absence of expression of T cell, B cell, or macrophage mark-
ers or intracellular endogenous peroxidase, which marks both
macrophages and eosinophils in rat. Flow cytometric methodol-
ogy for DC phenotyping, including details of mAbs and isotype
controls, and analyses of endocytosis of FITC dextran are as pre-
viously described (11).
For confocal microscopy studies using whole mounts (see Fig.
1), rat tracheas were stored in 100% ethanol at 4
 
 
 
C overnight,
and thereafter washed for 5 h in PBS at room temperature. The
samples were incubated with a mixture of mAb Ox6 anti–rat
MHC class II or Ox21 isotype control (neat culture supernatant)
and rabbit antiserum to rat laminin (1/100; DakoCytomation)
for 40 h, washed for 5 h, and then incubated with 0.8 
 
 
 
g/ml
Cy3-labeled goat anti–mouse IgG (Jackson ImmunoResearch
Laboratories) in combination with Cy5-labeled goat anti–rabbit
IgG (1/200; Amersham Biosciences) for 24 h. The specimens
were washed for 5 h and mounted in plastic slides. Fluorescent
images of the immunostained whole mount preparations were
obtained with a confocal laser scanning microscope (MRC-
1000; Bio-Rad Laboratories). The preparations were optically
sectioned by scanning at increasing focus depths (typically in
steps of 1 
 
 
 
m) from the surface epithelial side. Identical series of
optical images at increasing depths (image stacks) from one field
were obtained for each wavelength. These image stacks were
then merged and the three dimensional information (xyz axis)
obtained were analyzed with Object-Image 2.08 software (an ex-
tended version of NIH image).
For confocal microscopy studies using 10-
 
 
 
m frozen tracheal
sections, postfixed samples were first incubated for 1 h with mAb
R73 (IgG1) anti–rat TcR
 
  
 
, followed by 0.8 
 
 
 
g/ml Cy3-
labeled goat anti–mouse IgG for 30 min. The sections were then
incubated for 1 h with biotinylated mAb Ox6 anti–rat MHC class
II (to identify DCs) mixed with 10% mouse serum to block non-
specific binding, and finally with Cy2-labeled streptavidin (Am-
ersham Biosciences) for 30 min. Isotype control experiments per-
formed in parallel were always negative. Analysis of resulting
images was as described above.
The technique used in studies to track DC migration to RLN
was developed independently here and was comparable to that
used in recent murine studies (18). In brief, rats were anesthe-
tized, and 100 
 
 
 
l of 10 mg/ml FITC dextran in PBS was admin-
istered via intratracheal intubation at a point immediately belowT
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the epiglottis. 24 h later parathymic lymph nodes (PTLN) were
removed and single cell suspensions were prepared for analyses of
FITC staining on MHC class II
 
hi 
 
DCs, identified via PE-conju-
gated mAb Ox6.
 
Lung Function and Methacholine (MCh) Hyperresponsiveness.
 
The techniques used were as previously described (19). In brief,
lung function was measured by forced oscillation using a com-
puter-controlled piston ventilator (
 
f
 
lexivent
 
®
 
; Scireq), which de-
livers both tidal ventilation and the complex wave forms (19
components between 0.5 and 20 Hz) used to measure respiratory
impedance (Zrs). Airway and lung tissue mechanics are calcu-
lated by fitting the constant phase model to Zrs (Zrs 
 
  
 
Raw 
 
 
 
j
 
 
 
Iaw 
 
  
 
(G-jH)/
 
 
 
 
 
, where Raw and Iaw are airway resistance
and inertance, respectively, G and H are the coefficients of tissue
damping and elastance, respectively, 
 
  
 
is the angular frequency,
and 
 
  
 
represents the constant phase behavior of G and H). After
baseline lung function, MCh challenge was performed by deliv-
ering aerosols (2 min) of saline (control) and MCh (0.1, 0.3, 1.0,
3.0, 10.0, and 30.0 mg/ml) during tidal ventilation. Five mea-
surements of Zrs were made after each dose and peak responses
were reported.
 
Online Supplemental Material.
 
We provide a detailed descrip-
tion of the cytometry raw data from representative experiments
that were used to compile the composite figures shown in the
main text. These online supplemental figures are available at http://
www.jem.org/cgi/content/full/jem.20021328/DC1.
 
Results
 
Fig. 1 illustrates quantitative analyses of bone marrow–
derived cells in respiratory tract tissues using light and con-
focal laser microscopy, and flow cytometry. Consistent
with earlier findings (8, 14), prominent populations of
MHC class II
 
  
 
DCs were observed in frozen sections
within the epithelium and underlying lamina propria of the
normal trachea and within the alveolar wall (unpublished
data). OVA aerosol challenge of animals primed with
OVA/ALOH to elicit Th2-polarized immunity triggered
the rapid influx of DCs into the airway wall. Fig. 1, A–C,
represents superimposed Z-plane confocal microscopy im-
ages providing an overview of the total DC population
 
within the tracheal epithelium and underlying submucosa
to a depth of 
 
 
 
30 microns below the epithelial basement
membrane at 0 (Fig. 1 A), 2 (Fig. 1 B), and 24 h (Fig. 1 C)
after cessation of OVA exposure. As demonstrated in Fig. 1
D, the bulk of DC recruitment occurs within the first 2 h,
and the highest numbers of influxing cells are observed
within the submucosa. Parallel infiltration of T cells was
also observed (predominantly CD4
 
 
 
; unpublished data),
which was accompanied by eosinophils, with peak num-
bers observed at 24 h. We additionally enumerated DCs in
collagenase digests of peripheral lung by flow cytometry
(Fig. 1 E) and observed a parallel response in this tissue
compartment. It should be noted that the figures shown
here are likely to underestimate overall in vivo population
sizes due to the loss of some DCs during tissue digestion.
Next, we performed lung function studies as shown in
Fig. 2. Exposure of sensitized animals to a single OVA
aerosol challenge induced hyperresponsiveness to MCh
24 h later, as demonstrated by the shift in the MCh dose re-
sponse curve in Fig. 2 A. The technique used (19) provides
independent measures of MCh responsiveness in the con-
ducting airways (airway resistance in Fig. 2 A) versus pe-
ripheral lung tissues (tissue elastance in Fig. 2 B), and it is
noteworthy that the development of MCh hyperrespon-
siveness was restricted to the airways. These findings, nota-
bly antigen aerosol–induced recruitment of T cells and
eosinophils into airway tissues and accompanying expres-
sion of airways hyperresponsiveness (AHR), are hallmarks
of the human asthmatic response to allergen challenge and
indicate the general suitability of this system for modeling
the human disease.
In Fig. 3 we sought initial information on the functional
phenotype of respiratory tract DCs after aerosol challenge
of sensitized rats, using a series of flow cytometric analyses
of airway and lung-derived cell populations. The dot plot
in Fig. 3 A illustrates the side scatter (SSC) and MHC class
II gating strategies used to analyze these DC populations.
Fig. 3 B illustrates the changes occurring in surface marker
expression within the overall tracheal DC population (R1)
Figure 1. In situ analysis of respiratory tract cell popula-
tions. (A–C) Tracheal epithelium stained for MHC class II.
Sections were taken at (A) 0, (B) 2, and (C) 24 h after
OVA aerosol challenge of primed animals. Images are
projections along the z axis (“top” view) from stacks of 30
optical sections acquired at 2- m increments at  100
magnification. (D) Tracheal sections from primed OVA/
ALOH animals after OVA aerosol exposure, stained for
eosinophils, T cells, and DCs. Cells were quantitated by
light (Epithelial DC, T-cells, Eos) confocal microscopy
(Submucosal DC). Data are mean   SD from three to five
observations for each cell type. (E) Lung tissue was isolated
at the indicated time points after challenge and single cell
suspensions were prepared and immunostained. DCs were
enumerated by flow cytometry and results were expressed
as numbers recovered per gram wet weight (mean   SD
from three experiments).T
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over the 24-h period after challenge (see also Figs. S2–S4,
available at http://www.jem.org/cgi/content/full/jem.
20021328/DC1). All markers appeared stably expressed
with the exception of CD86, which demonstrated a prom-
inent but transient increase at 2 h after exposure. This ob-
servation suggested that a subset of local DCs may have
been undergoing functional maturation in situ. We further
tested this possibility by assessing endocytic activity, which
is known to markedly decline in DCs undergoing cyto-
kine-driven functional maturation (20). Fig. 3 C illustrates
endocytosis within R1 DCs and clearly indicates that tran-
sient shutdown of endocytic activity accompanies up-regu-
lation of CD86. It is additionally noteworthy that en-
docytic activity continues in decline to 24 h, at which time
incoming immature DCs represent a prominent compo-
nent of the overall population. This suggests that immature
DCs recruited into airway tissues during acute inflamma-
tion may initially be weakly endocytic (i.e., monocyte-like)
and may require further differentiation in situ to develop
this capacity. In support of this possibility, we have ob-
served that endocytic activity is directly associated with
SSC and MHC class II expression within the resting tra-
cheal DC population (unpublished data).
In Fig. 3 D further analyses were performed involving
segregation of the overall R1 DC population into three
distinct subregions based on variable expression of MHC
class II and SSC (Fig. 3 A, R2–R4). R2 defines the popula-
tion of cells low in both SSC and MHC class II expression,
 
which are likely to include the recently arrived small im-
mature DCs (15% of resident DCs in normal resting tra-
chea). R3 DC are also SSC low but are MHC class II high
(66% of resident DCs), whereas the remainder (R4: 19%)
are SSC high/MHC class II high, characteristics of mature
(activated) DCs. Increases in numbers occurred within all
three regions during the 24-h period after challenge, the
most rapid and pronounced change being observed in R4
at 2 h.
Further examination of CD86 staining on tracheal DCs
indicated that expression was most prominent amongst the
DC subpopulation expressing the highest levels of MHC
class II (Fig. S4, available at http://www.jem.org/cgi/
content/full/jem.20021328/DC1). This is illustrated in Fig.
3, E and F, which focuses on R4 DCs and demonstrates that
after correction for background staining with isotype con-
trol (Fig. 3 E), 66% of the MHC class II
 
hi 
 
DCs express
CD86 (Fig. 3 F). It should be noted that the up-regulation
of CD86 expression observed here relates to an increase in
the number of cells in the positive gate. The mean intensity
of expression of CD86 amongst the positive population at
2 h did not significantly increase, relative to that of the
smaller number of CD86
 
  
 
tracheal DCs present at 0 h.
Fig. 3 G illustrates changes in CD86 expression on
MHC class II
 
  
 
tracheal DCs. A distinct hierarchy is evi-
dent with the greatest increases occurring in R3 and R4 at
2 h with levels returning close to baseline by 24 h,
whereas the increases in R2 are maintained. Fig. 3, D and
G, collectively suggest that the DC population exhibiting
the most rapid up-regulation of CD86 expression is pre-
dominantly derived from medium to large resident DCs
present at the time of challenge, rather than from the
smaller incoming precursors.
In Fig. 3 H we examined accompanying changes in DCs
in the draining (parathymic) RLN, focusing upon “ma-
ture” DCs gated on the basis of high MHC class II expres-
sion together with minimal binding of isotype control. The
same gates were applied directly for all other relevant
analyses (Fig. S5, available at http://www.jem.org/cgi/
content/full/jem.20021328/DC1). In resting RLN, MHC
class II
 
hi 
 
and CD86
 
hi 
 
cells comprise 3.2% of the overall
MHC class II
 
  
 
DC population (Fig. 3 H). DCs with com-
parable MHC class II expression characteristics have re-
cently been implicated in translocation of antigen (FITC
dextran) from the tracheal surface to RLN in unstimulated
mice (18). Using comparable methodology we have ob-
served that a high proportion of cells (40.2 
 
  
 
8.3%; 
 
n 
 
  
 
3)
in the MHC class II
 
hi 
 
gate in PTLN from unstimulated rats
(compared with 
 
 
 
3% of their MHC class II
 
lo 
 
counterparts)
are FITC positive within 24 h of administration of FITC
dextran onto the tracheal surface, which is consistent with
findings in the mouse. We additionally observed that cells
with characteristic MHC class II
 
hi 
 
and CD86
 
hi 
 
expression
increase progressively in the PTLN of OVA-sensitized ani-
mals over the 24-h period after challenge, peaking at 7.1%
of the overall MHC class II
 
  
 
DC population by 24 h before
returning to baseline at 48 h (Fig. 3 H). In contrast, analy-
ses of control lymph nodes draining other sites (superficial
Figure 2. AHR after exposure to aerosolized OVA. Sensitized animals
(n   6 per group;  ) together with naive controls ( ) were exposed to
aerosolized OVA, and 24 h later MCh challenge was performed. The top
shows a left shift in the airway dose response curve to MCh contrasted
with no change in parenchymal responsiveness (bottom). Differences be-
tween test and control groups in this experiment (and in Figs. 3–6) were
analyzed by Student’s t test. *, P   0.01; **, P   0.05.T
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cervical lymph nodes) at the peak of the PTLN response
demonstrated no comparable up-regulation of CD86 ex-
pression (unpublished data).
Next, we extended analyses to peripheral lung DCs in
the same animals. The immunostaining profiles of these
DCs (Fig. 3 J) differed in several respects from their airway-
derived counterparts, notably with higher resting levels of
CD8 and lower CD4 and CD11b/c, but expression of
these markers and more importantly CD86, did not change
during the 24-h period after challenge (see also Figs. S6 and
S7, available at http://www.jem.org/cgi/content/full/
jem.20021328/CD1). Additionally, there was no evidence
of changes in endocytic function in peripheral lung DCs at
24 h (Fig. 3 K).
In Fig. 4 we addressed the central issue of the APC func-
tion of these DCs, in particular the presentation of OVA
acquired in vivo during aerosol challenge. In these experi-
ments DCs were sorted to 
 
 
 
95% purity from tracheas and
PTLN of OVA-immune and naive rats before and after
OVA aerosol exposure, and cocultured with OVA-respon-
sive CD4
 
  
 
T cells. The resultant T cell activation was mea-
sured as 
 
3
 
H-DNA synthesis. Consistent with previous find-
ings (10), DCs from OVA aerosol–exposed naive rats
induced minimal OVA-specific T cell proliferation. How-
ever, in OVA-sensitized animals, OVA-bearing DCs ex-
pressing mature APC activity were observed in the tracheal
mucosa 2 h after OVA exposure (Fig. 4 A). These cells
were no longer present in the mucosa at 24 h (Fig. 4 A),
but MHC class II
 
hi 
 
DCs with correspondingly high levels of
OVA-specific APC activity now appeared de novo in the
draining PTLN (Fig. 4 B). Taken together with earlier ob-
servations of migration of antigen-bearing DCs to thoracic
Figure 3. Flow cytometric analysis of
DCs after OVA aerosol challenge of OVA-
primed animals. Data are representative of a
series (A, E, and F) or mean   SE from
three to five experiments. (A) Flow cyto-
metric analysis of total tracheal digest cells
indicating gating for total DCs (R1) and
subregions (R2–R4), based on SSC and
MHC class II expression profiles. (B) Sur-
face marker expression (after correction for
background staining with isotype control)
in total MHC class II  DC populations (R1)
in the trachea at 0 (open bars), 2 (solid bars),
and 24 h (hatched bars) after challenge (*,
P   0.01 compared with 0 and 24 h). (C)
Endocytic activity of R1 tracheal DCs at 2,
24, and 48 h after challenge as determined
by 10-min dextran FITC uptake with try-
pan blue quenching at 37 C minus uptake
at 4 C. Activity was significantly reduced
relative to unexposed animals (0 h). *, P  
0.04; **, P   0.01. (D) Relative numeric
changes in tracheal DCs within each gating
region at 2 (solid bars) and 24 h (hatched
bars) after challenge compared with control
immunized, nonaerosol challenged animals
(open bars). (E and F) Expression of CD86
and MHC class II by R4 tracheal DCs at
2 h after challenge. Nonspecific binding of
isotype control (E) versus staining with anti-
CD86 on the MHC class IIhi subset. (G)
Changes in CD86 expression on tracheal
DCs in subregions R2–R4 as designated in
A and D. Significance of increase relative to
0 h. *, P   0.01; **, P   0.001. (H) Flow
cytometry analysis of DCs in PTLN after
aerosol challenge of sensitized animals. The
gating strategy comprised initial selection of
total DCs (as per R1 in A), followed sequentially by gating for high MHC class II and low isotype control
binding, and the same gates applied directly to obtain percentage of CD86 expression (see Fig. S5, available at
http://www.jem.org/cgi/content/full.jem.20021328/DC1). MHC class IIhi CD86hi DCs are shown as per-
centage of total DCs at 0 h compared with animals at 2, 24, and 48 h after challenge.  0 h: *, P   0.01; **,
P   0.001. (J) Surface marker expressions by R1 DCs in the parenchymal lung at 0 (open bars), 2 (solid bars),
and 24 h (hatched bars) after challenge. (K) Endocytic activity of R1 parenchymal lung DCs at 24 h after
challenge compared to unexposed animals (t0), determined as per C.T
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lymph nodes in rats (12) and mice (18) after airway chal-
lenge via intratracheal instillation, and the demonstration
above of the sequential appearance of MHC class II
 
hi
 
CD86
 
hi 
 
DCs in the airway mucosa and subsequently the
PTLN, these findings are consistent with onward migration
of OVA-presenting DCs from the site of antigen deposi-
tion in the airway to the draining lymph node. Although it
is likely that such migrating DCs might be responsible for
the transient peak of OVA-specific APC activity observed
in the PTLN (Fig. 4 B), the possibility that airway-derived
DCs may pass on antigen to their lymph node counterparts
(which in turn become activated) cannot be excluded. In
the experiments shown in Fig. 4 C we demonstrate that the
in vitro APC activity of the airway DCs sampled at 2 h af-
ter OVA exposure can be partially blocked by mAb against
the costimulator CD86. The efficiency of this blockade
ranged from 25 to 55%.
Next, we sought to further elucidate the mechanisms
underlying T cell–induced DC maturation. The upper
panels of Fig. 5 A show DC–T cell interactions in situ in
the airway mucosa from an OVA-challenged rat, using
confocal microscopy. Fig. 5, A–C, displays optical sections
one micron apart, illustrating clustering between DCs
(green) and T cells (red; contact regions are yellow). In Fig.
5 D, we scored individual T cells in randomly selected sec-
tions at each time point for contact with DCs, clearly dem-
onstrating the continuous high level of interaction between
resident DCs and transiting T cells in the resting state,
which increases further after challenge. The relative num-
ber of clustered T cells was also determined by factoring in
information (refer to Fig. 1) on the total number of T cells
present at each time point, and it is evident that a progres-
sive increase occurs over the 24 h after allergen challenge.
We obtained comparable findings for clustering of CD2
 
  
 
T
cells with DCs (Fig. S8, available at http://www.jem.org/
cgi/content/full/jem.20021328/DC1). We sought evi-
dence that these DC–T cell interactions were associated
with T cell activation. Analyses of IL-2R expression on
isolated airway T cells from challenged animals indicated a
marked increase at 24 h (Fig. 5 E). Next, we examined the
potential mechanism of CD86 up-regulation by coculture
of resting airway DCs with CD4
 
  
 
T cells from naive or
OVA-primed animals, plus soluble OVA, for 3 h, corre-
sponding to 1 h of aerosol exposure plus 2 h of rest before
sampling, as used above (Fig. 5 F). The results indicate that
CD86 up-regulation required the presence of antigen-spe-
cific T memory cells plus antigen. We additionally ob-
served up-regulation of MHC class II expression on these
DCs (Fig. S9, available at http://www.jem.org/cgi/content/
full/jem.20021328/DC1).
In view of recent findings of histamine-mediated CD86
up-regulation on human monocyte–derived DCs (21), we
attempted to abrogate antigen-induced up-regulation of
CD86 on airway DCs by pretreatment of animals with the
H-1 receptor antagonist mepyramine in combination with
the 5-HT receptor antagonist methysergide (22), and also
attempted to reproduce the in vitro up-regulation shown
in Fig. 5 F with 10
 
 
 
5 
 
M histamine, but without success
(unpublished data). Additionally, we transferred OVA-spe-
cific IgE-containing serum to naive animals before OVA
exposure, but no CD86 up-regulation on airway DCs was
observed in recipients (unpublished data).
Finally, we questioned whether these effects were re-
stricted to animals primed for Th2 responses by repeating
the OVA aerosol challenges in animals preprimed with
OVA in complete Freund’s adjuvant, which stimulates
Th1-polarized immunity. The key findings from these ex-
periments were transient up-regulation of CD86 expres-
sion at 2 h after challenge (Fig. 6 A) and subsequent expres-
sion of AHR (Fig. 6 B), analogous to Th2-primed animals.
Additionally, aerosol-induced DC recruitment occurred in
these animals at levels equivalent to the Th2-primed groups
Figure 4. Antigen presentation by purified airway and lymph node
DCs. Purified DCs from challenged animals were used to stimulate a
CD4  OVA-specific T cell line for 48 h. T cell stimulation (3H-DNA
synthesis as CPM/culture) is shown as mean   SE from three or more
experiments (A and B) or from individual experiments (C). (A) OVA
presentation by tracheal DCs isolated from OVA-immune animals 2 ( )
and 24 h ( ) after challenge, or from naive animals 2 h ( ) after chal-
lenge. 2 h   0 h and 24 h: *, P   0.05–0.01. (B) Total PTLN DCs were
purified at 2 ( ) or 24 h ( ) after OVA aerosol challenge and addition-
ally, sorted into MHC class IIhi ( ) or MHC class IIlow ( ) expressing cells
(as per Fig. 3) at the 24-h time point. OVA presentation by PTLN DCs is
maximal at 24 h after aerosol challenge and was restricted to the MHC
class IIhi population of DCs. (C) Tracheal DCs isolated 2 h after challenge
were used to stimulate OVA-specific T cells in the absence ( ) or pres-
ence ( ) of blocking antibody to CD86. In experiments 3 and 4, control
cultures contained isotype control mAb versus medium only in control
cultures in experiments 1 and 2. Data are normalized against the OVA-
specific T cell response (3H-DNA synthesis at 72 h) in the absence of
blocking antibody.  control: *, P   0.05; **, P   0.01.T
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(unpublished data). Interestingly, there is a small but signif-
icant increase in CD80 expression at 2 h, which was not
observed in Th2-primed animals.
Discussion
Asthma is a chronic inflammatory disease, in which the
principal target tissues are the conducting airway mucosae
(1, 23–25). Studies on airway mucosal biopsies from asth-
matics have revealed a characteristic pattern of tissue re-
modelling, which is believed to be responsible for the al-
tered mechanical properties of the airways and for their
exaggerated responsiveness to bronchoconstrictor stimuli
(1, 23–25). The disease process is multifactorial in origin,
and one of the most important predisposing factors is al-
lergy, as indicated by the strong association between risk
for asthma and serum IgE (26). The presence of activated
eosinophils and Th2 cells, characteristic of asthmatic airway
biopsies (1, 24, 27), further emphasizes the importance of
allergy in asthma pathogenesis.
The most informative studies on disease expression in
target tissues have involved deliberate aeroallergen expo-
sure of allergic volunteers and subsequent kinetic analysis
of the sequelae. The response in chronic asthmatics is typi-
cally biphasic, comprising transient early bronchospasm
within minutes of challenge that is associated with IgE-
dependent mast cell degranulation (25, 28), and a subse-
quent wave of airway obstruction (the late phase reaction
[LPR]) occurring several hours later, in association with
the appearance in the airway mucosa of eosinophils and ac-
tivated T cells (25, 28), together with heightened airway
responsiveness to MCh.
The principal trigger for the LPR in atopic asthma is
believed to be activated allergen-specific Th2 cells, with
Figure 5. DC–T cell interactions in
airway mucosa. (A–C) Confocal micros-
copy of tracheal sections 2 h after chal-
lenge of OVA-immune rats stained for
MHC II (green, DCs) and TcR   (red,
T cells). Dual staining contact points ap-
pear yellow. Each panel in the series
represents a 1- m optical section shown
in ascending order, where individual
DCs can be seen interacting with  1 T
cells. (D) Individual T cells (n    50–
100) were scored for direct contact with
DCs, and numbers in contact were ex-
pressed as a percentage of total T cells.
Relative numbers of T cells at each time
point were determined by factoring in
data on absolute cell numbers per unit
area of tissue from Fig. 1 D. *, P   0.05
relative to 0 h, based on mean data from
five experiments. (E) IL-2R   T cells
were initially enumerated as a percent-
age of total T cells by flow cytometric
analysis of tracheal digests from exposed
(solid bars) or control (open bars) ani-
mals in five experiments, and finally ex-
pressed as numbers of IL-2R  T cells
per unit area of epithelium by reference
to data in Fig. 1 D, yielding five data
points for each group at each time point.
Data analysis used means derived from
these data points. 24 h   2 h in OVA-
exposed animals: *, P   0.05. (F) Tra-
cheal DCs from naive animals were cul-
tured alone or in the presence of either
control or OVA-immune T cells at a
density of 20:1 (T cell/DC). After the
addition of 50  g/ml soluble OVA,
CD86 expression was examined (as in
Fig. 3) at 0 and 3 or 4 h (data shown are
for 3 h and are representative of a series
of five experiments). Test culture (solid
bar)   controls (open bars). *, P   0.02
based on comparisons of means derived
from five data points for each manipula-
tion. Raw data from an exemplary
experiment are illustrated in Fig. S9,
available at http://www.jem.org/cgi/
content/full.jem.20021328/DC1.T
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the eosinophil component of the response being stimu-
lated by products from these Th2 cells, particularly IL-5
(29). Recent findings demonstrating induction of LPRs in
cat-allergic subjects with non–IgE-binding cat-specific
peptides spanning defined T cell epitopes provide support
for this hypothesis (5). However, the mechanisms that reg-
ulate T cell activation at sites of tissue damage in asthmat-
ics remain poorly understood and are the subject of in-
creasingly intensive research in animal model systems. Of
particular interest are issues related to regulation of local
APC functions.
Immunohistochemical studies in a range of species have
identified DCs as the sole resident population of profes-
sional APCs in respiratory tract tissues (14, 30). Reports
from our group (7, 8) and others (31, 32) indicate that
these DCs are distributed as dense, contiguous networks, in
particular within the lining of the airways, which is the
principal site of impaction of inhaled particles, wherein the
DCs occur in densities up to 1,000 per mm2 epithelium (7,
8, 31, 32). The functions of these DCs are tightly con-
trolled. As described in other organ systems (33), DCs iso-
lated from resting respiratory tract tissues are specialized for
uptake and processing of inhaled antigen, lacking capacity
for effective presentation to T cells (10, 11). The eventual
development of full APC competence by these DCs re-
quires a cytokine-dependent maturation step, suggesting
that they normally serve an exclusively sentinel function in
the airway wall, which is restricted to antigen acquisition,
subsequent presentation to the T cell system occurring only
after migration to and subsequent maturation within RLN
(10, 11, 34).
However, interpretation of results from these animal
models in relation to asthma pathogenesis is complicated by
the uncertain relationship between the respiratory tract DC
populations used in these investigations, and the DCs at
sites of inflammation in the airway mucosa in asthma. Pub-
lished studies on DC function in experimental asthma
models have focused primarily on populations on the alve-
olar surface that are accessible by BAL (13, 35), or on “re-
spiratory tract–derived” DCs harvested from RLN (12, 13,
18, 35), whereas studies on tissue-derived DCs from the re-
spiratory tract have been restricted to mixed populations
obtained from enzymatic digests of whole lung (12, 13).
Such whole lung DC preparations would contain a high
proportion of parenchymal DCs from tissue microenviron-
ments within the peripheral lung that are distal to the le-
sional site(s) in asthma. DCs in the parenchyma have previ-
ously been demonstrated to differ significantly from their
counterparts in the conducting airway mucosae with re-
spect to surface phenotype (31, 36), turnover rate (9), and
kinetics of postnatal development (37). Of particular note,
airway mucosal dendritic cells (AMDC) exhibit a uniquely
rapid steady state half-life of  36 h, in contrast to  10 d
for peripheral lung DCs (9). This difference reflects relative
levels of local stimulation from inhaled irritants/antigens,
which is markedly more intense in the conducting airways
than at the lung periphery due to the aerodynamic charac-
teristics of the respiratory tract (38). We hypothesized that
these variations may have important functional implications
with respect to responses to antigen challenge of different
respiratory tract DC populations. We have addressed this
important issue via a series of parallel studies on purified
DCs isolated from large conducting airways (trachea), pe-
ripheral lung, and RLN draining the upper airways, in
OVA-sensitized rats challenged with aerosolized OVA.
The salient findings from this study are as follows: (a) in-
haled antigen is efficiently acquired by local AMDC via en-
docytosis (Figs. 3 C and 4 A); (b) these DCs are in continu-
ous communication via clustering with transiting T cells
(Fig. 5 D); the mechanisms underlying these interactions
remain to be defined, but may involve ICAM-1 (CD54;
reference 39), which is constitutively expressed by AMDC
Figure 6. Responses to OVA aerosol challenge in rats primed for Th1
immunity with OVA/complete Freund’s adjuvant. DCs from tracheal
digests 2 and 24 h after challenge were immunostained as per Fig. 3. (A)
illustrates time-dependent changes in CD80 ( ) and CD86 ( ) expres-
sion after aerosol exposure. CD80/CD86  DCs are shown as a percent-
age of total MHC class II  DCs (mean   SE from three experiments).
Controls and gating strategies are as described in Fig. 3. MCh challenge
was performed on parallel groups (n   5) of control ( ) and OVA/com-
plete Freund’s adjuvant–primed ( ) animals. (B) illustrates a left shift in
the MCh dose response curve, contrasting with no change in parenchy-
mal responses shown in C. *, P   0.01; **, P   0.05.T
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(Fig. 3 B); (c) in sensitized, but not naive, animals CD86
expression is rapidly triggered on AMDC after OVA inha-
lation (Figs. 3 B, G, and 5 F); the majority of airway T cells
exhibit the Th memory phenotype (40–43) and we specu-
late that OVA-specific Th memory cells mediate the
AMDC activation observed here; on the basis of previous
reports it is feasible that this might be driven by T cell–
derived CD40L (44, 45) in combination with cytokines
such as GM-CSF (46); (d) within the same time frame,
AMDC develop capacity to present antigen (Fig. 4 A); ac-
quisition of APC activity is accompanied by CD86 up-reg-
ulation but in vitro CD86 blockade inhibits only  50% of
this activity, thus CD86 might be a surrogate marker for
other key costimulatory molecules; follow-up experiments
involving in vivo blockade are required to elucidate this
question; a likely candidate in this context is ICOSL,
which has recently been shown to be induced on mature
DCs in lung RLN in a mouse asthma model (47); (e) these
interactions result in local T cell activation/IL-2R expres-
sion (Fig. 5 E), which is associated in turn with develop-
ment of AHR (Fig. 2 A); based on observations from other
laboratories, activation of incoming eosinophils that peak at
24 h (Fig. 1 D) might be a key element in this process (1,
23); (f) between 2 and 24 h, CD86hi DCs with APC activ-
ity decline markedly in number within the airway mucosa
(Figs. 3 B, G, and 4 A), whereas reciprocally increasing in
RLN (Figs. 3 H and 4 B); this might be due in part to “ex-
haustion” of these cells in situ (48) but we speculate on the
basis of earlier tracking studies in a mouse asthma model
(18) plus our present data on the sequential appearance of
DCs with the relevant functional phenotype in the airway
mucosa and subsequently in the RLN, that emigration of
mature AMDC to the RLN also contributes to the pattern
observed; and (g) during the timeframe of these changes
within the resident AMDC population, a large influx of
new DCs is recruited into airway tissues (Fig. 1, A–D; ref-
erence 15); on the basis of their phenotypic characteristics
we speculate that these represent immature DCs recruited
to replace antigen-bearing emigrants; little direct informa-
tion is available concerning control of this trafficking, aside
from earlier observations on responsiveness of resident lung
DCs to CC chemokines (15, 16); mast cells are unlikely to
be a significant source of the relevant chemokines as the
DC recruitment response cannot be reproduced by adop-
tive transfer of serum containing OVA-specific IgE.
Two observations from this study merit specific com-
ment. First, it is clear that transient up-regulation of the
APC functions of respiratory tract DCs after antigen aero-
sol exposure is restricted in this model to populations in the
airway mucosa, and does not occur in lung parenchymal
DCs (Fig. 3, J and K), despite the fact that DC recruitment
occurs in the peripheral lung (Fig. 1 E). The latter suggests
that significant levels of inhaled antigen reach this part of
the respiratory tract, and this is supported by our observa-
tions (49) demonstrating major changes in peripheral lung
tissue elastance in rats sensitized to OVA after OVA chal-
lenge under conditions identical to those used here. The
absence of activated DCs in the peripheral lungs of animals
in the present experiments contrasts with findings in other
studies involving analysis of homogenized whole murine
lungs after local challenge of sensitized animals (12, 13).
However, in the present experiments peripheral lung was
initially dissected free of hilar tissue containing the bulk of
the conducting airways before digestion, whereas the
whole lung tissue homogenates used in these latter experi-
ments (12, 13) would contain a mixture of DCs derived
from both parenchymal lung and from airway mucosa. Our
present data suggests that the bulk of the APC activity de-
tected in these homogenates (12, 13) is therefore likely to
be attributable to airway mucosal-derived DCs.
It is also relevant to note that we have recently shown
that the site(s) of allergen-induced inflammation in the lung
determines the site(s) at which MCh hyperresponsiveness
develops (50) and the lack of hyperresponsiveness in pe-
ripheral lung tissue in the current model (Fig. 2 B) is thus
consistent with the lack of local T cell–mediated inflamma-
tion (and by inference DC maturation) at this site. These
observations can only be made when using physiological
techniques capable of partitioning lung responses into com-
ponents representing the airways and lung parenchyma sep-
arately, such as those used here. The reasons underlying
this strict partitioning of DC/T cell responses are not fully
clear and may reflect intrinsic differences between DC
populations at respective sites (e.g., note variations in CD4,
CD8, and CD11b/c; Fig. 3, B vs. J), regional differences in
regulation by DC inhibitory macrophages (10), and/or
variations in specific Th memory cell migration patterns in
the two tissue microenvironments. In relation to the latter
it should be reiterated that T cell trafficking to the airway
mucosa would favor the transit of specific mucosal homing
T cells that preferentially extravasate in tissues that are part
of the common mucosal immune system (6), whereas ex-
travasation from the vascular bed in peripheral lung tissues
is essentially a random process (51). Additionally, our ear-
lier immunohistochemical studies (52) indicate that T cell
density within the lung parenchyma is markedly lower than
that in the airway submucosa (Fig. 5 and Fig. S8, available
at http://www.jem.org/cgi/content/full/jem.20021328/
DC1), hence minimizing the chances for interactions be-
tween antigen-bearing DCs and antigen-specific Th mem-
ory cells in the peripheral lung.
A recent report involving a mouse asthma model de-
tected the presence of long-lived antigen-laden APCs in
BAL, but not in lung homogenates from sensitized ani-
mals, after several cycles of aerosol exposure (13). How-
ever, in our rat model we have been unable to detect com-
parable long-lived APCs in the airway mucosa, after up to
nine cycles of aerosol exposure (unpublished data), which,
taken together with the earlier findings, suggests that the
distribution of these cells might be restricted to the periph-
eral lung. It will also be of interest to determine in future
studies whether T cells activated via these long-lived anti-
gen-laden APCs can traffic to asthma lesional sites in the
airway mucosa and thus contribute to disease progression.
The precise identity of these long-lived peripheral lung
APCs, and their presence in species other than the mouse,T
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also requires clarification. These cells reportedly express
phenotypic characteristics typical of DCs (13), with the ex-
ception of extremely long half-life, which in this tissue
compartment has previously only been described for local
macrophages (53). It is also noteworthy that they manifest
up-regulation of CD80 expression (13), as opposed to
CD86, which is the defining feature of the AMDC re-
sponse in the present model. We have previously reported
that GM-CSF exposure of murine pulmonary alveolar
macrophage changes their functional phenotype from
markedly suppressive to supportive of T cell activation
(54). Moreover, GM-CSF is produced at high levels in air-
way tissues of atopic asthmatics (55), along with Th2 cyto-
kines including IL-4 (27). Given the potency of GM-CSF
combined with IL-4 in promoting maturation of cells from
the monocyte/macrophage lineage into antigen-presenting
DCs (20), it is conceivable that the persistent APC popula-
tion detected on the alveolar surface of chronically aerosol-
challenged sensitized mice (13) may have arisen through a
similar mechanism. Overlap between the macrophage and
DC populations in murine BAL has previously been rec-
ognized via sharing of expression of markers such as
NLDC-145 (56) and it is noteworthy that the long-lived
DCs reported as appearing in murine BAL after allergen
exposure also express F4/80 (13). Comparable sharing of
phenotypic characteristics between pulmonary alveolar
macrophage and DCs in this compartment has been re-
ported in humans (57).
Finally, it is noteworthy that antigen-induced airway
DC/T cell activation and associated development of AHR
appears comparable in animals primed for Th1- (Fig. 6) or
Th2-polarized immunity (Figs. 1–5). This finding is consis-
tent with reports in murine models that indicate that AHR
can also be induced via Th1 pathways (58) and with studies
demonstrating similar T cell–associated pathology in airway
biopsies from atopic and nonatopic asthmatics (59). A simi-
lar role for Th1 immunity in the pathogenesis of chronic
atopic dermatitis has also been suggested, based on studies
in murine models (60) and direct observation of lesional
sites in humans (61).
We have recently demonstrated changes in the popula-
tion dynamics of AMDC in human atopic asthmatics after
aeroallergen challenge (62), which closely reflect those
demonstrated in this animal model. Collectively, the find-
ings from these studies have significant implications for drug
design in asthma. They provide the first plausible mecha-
nism for transient airway mucosal T cell activation during
the timeframe of the LPR at the specific lesional site in
asthma, and identify local DC–T cell interaction(s) and asso-
ciated functional changes in local DCs as key steps in the re-
sponse. The development of drug(s) targeted specifically at
these processes offers new possibilities for asthma control.
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